Novo Nordisk launches a next generation of FlexPen
Novo Nordisk announced the launch of a next generation of FlexPen® at the European Association for the Study of Diabetes Annual Meeting.
Novo Nordisk A/S, the world's largest maker of insulin, said Wednesday that it plans to expand its US headquarters in Princeton, New Jersey to accommodate future growth.